Clinical Trial Update: Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating lung concentrations of ceftazidime in patients with pneumonia, including ventilator-associated pneumonia, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• ceftazidime (ceftazidime)

Snippet

Sponsor: CHU de Reims | Conditions: Pneumonia | Phase 3 | Status: COMPLETED